Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combining cytarabine and mitoxantrone
in treating patients who have recurrent or refractory leukemia or lymphoma.